Oncology: The Mayo Clinic

Total Score People Score Events Score
79 58 27
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 What's New and Improved in the Care of Children with Rhabdomyosarcoma? Carola A. S. Arndt
Responding to Common Concerns of Patients with Cancer: What's New—In a Nutshell—From Research to Therapeutic Strategies Charles L. Loprinzi
Uncommon Lymphoproliferative Disorders (C01) Angela Dispenzieri
Rationally Combining Targeted and Pathway-Specific Agents Edith A Perez
Special Session David P Steensma
Education Sessions Gloria M. Petersen
April 6, 2013 AACR Annual Meetings Targeting Lymphoid Malignancies: Working from the Outside In Co-Chairpersons: John P. Leonard, Weill Cornell Medical Center, New York, NY, and John C. Byrd, The Ohio State University Comprehensive Cancer Center, Columbus, OH James R. Cerhan
Endocrine Resistance in Breast Cancer Chairperson: Nancy E. Davidson, University of Pittsburgh Cancer Institute, Pittsburgh, PA Matthew P . Goetz
DNA Damage Response: What Do We Know Now and What Will We Learn Next? Chairperson: Junjie Chen, The University of Texas MD Anderson Cancer Center, Houston, TX Junjie Chen
Genetic Epidemiology of Pancreatic Cancer Gloria M. Petersen, Mayo Clinic College of Medicine, Rochester, MN Gloria M. Petersen
January 31, 2013 5th Immunotherapeutics & Immunomonitoring The Immune System in Breast Cancer Initiation and Progression: Role of Epithelial to Mesenchymal Transition Keith Knutson
October 4, 2012 14th Annual Lynn Sage Breast Cancer Symposium Session 1 | Supportive Oncology Lynn C Hartmann
Benign Breast Disease and Risk: What’s New? Lynn C Hartmann
September 13, 2012 International Society of Gastrointestinal Oncology Bevacizumab Axel Grothey
Screening for Colorectal Cancer with Emphasis on Stool DNA David A. Ahlquist
Session 5 | Localized/Adjuvant Colorectal Cancer Axel Grothey
Case 1: Elderly Patient with Stage III Colon Cancer Joleen M. Hubbard
Laparoscopic Surgery of Rectal Cancer: Are We There Yet? Heidi Nelson
Molecular Markers, Molecular Signatures and Treatment Decision in Stage II Colon Cancer Daniel J. Sargent
August 3, 2011 21st Annual Mayo Clinic Hematology/Oncology Reviews What is New in the Treatment of Hepatobiliary Malignancies Steven R. Alberts
Role of Proton Therapy in GI Malignancies Jonathan Ashman
Management of Metastatic Colorectal Cancer Beyond First-line Therapy George Kim
Recent Advances in the Management of Neuroendocrine Tumors Michaela Banck
GI Cancers Steven R. Alberts
Update of the Oxford Meta-Analysis Adjuvant Data Edith A Perez
What is New on the Management of Triple Negative Breast Cancer Alvaro Moreno-Aspitia
Advances in Breast Cancer Surgery Sarah McLaughlin
Breast Cancer Alvaro Moreno-Aspitia
An Update on Thrombosis Aneel A. Ashrani
Management of ITP Pierre Noel
Benign Hematology Ruben A Mesa
What is New on the Treatment of Prostate Cancer Manish Kohli
Recent Developments in the Management of Sarcomas Gary Schwartz
What is New on the Management of Non-Hodgkin’s Lymphomas Thomas Habermann
What is New on the Management of Myelodysplastic Syndromes David P Steensma
What is New on the Management of Acute Myelogenous Leukemia’s James Foran
What is New on the Management of Chronic Myeloproliferative DisordersMesa Ruben A Mesa
Hematological Malignancies Ruben A Mesa
February 17, 2011 Mayo Clinic World Robotics Symposium in Gynecology Robotic Parametrial Ureteral Dissection, Ureterolysis and Reimplantation Javier F. Magrina
Why Robotics? Applications of Robotics in Gynecology Rosanne M.C. Kho
Welcome and Introductions Javier F. Magrina
Robotics in Benign Gynecology Javier F. Magrina
Videos | Robotic Techniques for Endometriosis Javier F. Magrina
Robotic Vaginal Cuff Closure, Management of Vaginal Cuff Dehiscence Rosanne M.C. Kho
Pre-Recorded Live Robotic Surgery | Infrarenal Aortic Lymphadenectomy Javier F. Magrina
Avoiding Complications Unique to Robotics Rosanne M.C. Kho
Bladder and Ureteral Injuries in Robotics: Prevention and Management Jeffrey L. Cornella
Pre-Recorded Live Robotic Sacrocolpopexy | Standard and Barbed Suture Techniques Rosanne M.C. Kho
Robotics in Urogynecology | Pros and Cons, Techniques Jeffrey L. Cornella
Announcements Rosanne M.C. Kho
Robotics in Complex Pelvic Surgery Rosanne M.C. Kho
Robotic Modified Posterior Pelvic Exenteration for Ovarian Cancer: Technique and Results Javier F. Magrina
Pre-Recorded Live Robotic Surgery | Endometrial Cancer Paul M. Magtibay
Nerve-Sparing Radical Hysterectomy | Applied Anatomy of the Pelvic Autonomic Nerves, Technique Javier F. Magrina
Announcements Javier F. Magrina
Robotics in Gynecologic Oncology Javier F. Magrina
October 21, 2010 Acute Care Psychiatry Clinical Review Cluster B Personality Disorder J. Michael Bostwick
Adult ADHD Daniel K. Hall-Flavin
Bipolar Depression & Rapid Cycling Bipolar Disorder Mark A. Frye
Monitoring & Managing Antidepressants J. Michael Bostwick
Augmentation Agents in Unipolar Depression Simon Kung
Treating Unipolar Depression Mark A. Frye
Bipolar vs. Unipolar Depression Timothy W. Lineberry
Obesity Treatment Approaches James R. Rundell
PTSD Timothy W. Lineberry
Managing Suicide Risk Timothy W. Lineberry
Substance Use Disorders in Psychosis & Mania Daniel K. Hall-Flavin
Acute Mania Treatment Mark A. Frye
Evaluating Psychosis in the ED Timothy W. Lineberry
Dementia Update | PSYCHIATRY TRACK James R. Rundell
Managing Sleep Problems in Patients w/Psychiatric Illness | PSYCHIATRY TRACK Lois E. Krahn
ECT Update | PSYCHIATRY TRACK Teresa A. Rummans
Transcranial Magnetic Stimulation | PSYCHIATRY TRACK Simon Kung
Role of Pharmacogenomics | PSYCHIATRY TRACK Mark A. Frye, Timothy W. Lineberry
ABFM Maintenance of Certification Self Assessment Module: Depression | FAMILY MEDICINE TRACK Kurt B. Angstman, John M. Wilkinson
SPECIAL ADDITIONAL OFFERING | Bipolar Disorder Masters Class Mark A. Frye
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities A Native American community perspective Judith S. Kaur,
Personalizing cancer therapy: Implications for health disparities Alex A Adjei
Plenary Session 8: Personalizing Cancer Prevention and Therapy Alex A Adjei
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved A Native American community perspective Judith S. Kaur,
Personalizing cancer therapy: Implications for health disparities Alex A Adjei
Personalizing Cancer Prevention and Therapy Alex A Adjei
February 11, 2010 Second Annual Conference The Sixth Vital Sign: What Every Oncologist Should Know About Molecular Oncology: Applications to Patient Care Predictive Biomarkers for Cancer Therapy Robert B. Diasio
Targeting the Tumor Cell Cycle Mitesh Borad
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Critical Review/Summary of Level of Evidence/Research Direction Debra L. Barton
Session 1: Ayurveda Debra L. Barton
Introduction/Welcome Debra L. Barton
Lunch Satellite Session: Ginseng for Supportive Care in Cancer Treatment Debra L. Barton
October 16, 2009 Eighth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy HER2 Dependence Edith A Perez
Case Presentation 2: Metastatic But Potentially Curable Axel Grothey
Case Presentation 3: Stage Iva After Primary Surgery for Synchronous Liver Metastases- Previously Untreated Axel Grothey
July 22, 2009 Eighth International Congress on the Future of Breast Cancer HER2-Driven Breast Cancer Edith A Perez
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Strategy for Preclinical Cardiovascular Safety Evaluation for Biologicals Hugo Vargas
March 9, 2009 Drug Development Latin America PANEL DISCUSSION Interactive Panel with Managers from Clinical Trials Offices of National Regulatory Agencies Edith A Perez
January 26, 2009 Biomarker Assay Development Moving a New Technology into the Routine Lab: Validation and Education Challenges Lawrence Oliver
January 26, 2009 Translational Cancer Medicine Moving a New Technology into the Routine Lab: Validation and Education Challenges Lawrence Oliver
November 23, 2008 Advanced Technology in Radiation Oncology Phase I Trial Of Intratumoral And Resection Cavity Administration Of A Measles Virus Derivative Expressing The Human Carcinoembryonic Antigen (CEA) In Patients With Recurrent Glioblastoma Multiforme. evanthia Galanis
November 21, 2008 The 13th Annual Scientific Meeting of the Society for Neuro-Oncology Is Response A Meaningful Surrogate For Survival Endpoints In Clinical Trials Involving Newly Diagnosed And Recurrent Glioblastoma Patients ? A North Central Cancer Treatment Group (NCCTG) Study. Kurt Jaeckle
June 27, 2008 American Society of Clinical Oncology Program Commitee P Leif Bergsagel, Edith A Perez
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty Alex A Adjei
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer Edith A Perez
developmental therapeutics-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer Edith A Perez
gastrointestinal (noncolorectal) cancer-- Multimodality Treatment of Bile Duct Tumors (M14) Steven R. Alberts
leukemia, myelodysplasia, and transplantation-- Myeloproliferative Disorders at the Cutting Edge Ayalew Tefferi
lymphoma and plasma cell disorders-- Initial Therapy for Multiple Myeloma: Considerations for an Integrated Risk- Adapted Approach S. Vincent Rajkumar
meet the professor sessions-- Multimodality Treatment of Bile Duct Tumors (M14) Steven R. Alberts
November 6, 2007 Chemotherapy Foundation Symposium XXV LENALIDOMIDE IN PLASMA CELL DYSCRASIAS S. Vincent Rajkumar
AEROSOLIZED GM-CSF Svetomir N. Markovic
October 16, 2007 Second Annual Putting Theory into Practice: Adaptive Clinical Trial Designs (Oct 16-17 SESSION I: Adaptive Dose-finding Designs for Oncology Single and Dual Agent Combinations Using Accumulated Data from all Patients (17:00 - 17:30) Sumithra J. Mandrekar
October 11, 2007 Sixth International Colorectal Cancer Congress Continuous vs. Intermittent Treatment Axel Grothey
Roundtable Discussion: Should There Be Planned Chemoholidays? Axel Grothey
How Long Do We Need to Treat Patients in the Adjuvant Setting? Axel Grothey
Moving EGFR Inhibitors to the Front-line and Further: Are We Ready Yet? Axel Grothey
North Central Cancer Treatment Group Steven R. Alberts
Ongoing Clinical Trials of Antiangiogenic Agents Axel Grothey
Should Anti-VEGF Therapy Continue Beyond Progession? Axel Grothey
Neoadjuvant Therapy Options and Duration: To Best Response or Resectability? Steven R. Alberts
Biomarker-Driven Trial Designs Daniel Sargent
Have We Maxed Out the Effect of PFS in First-line Therapy? Daniel Sargent, Axel Grothey
Novel VEGFR Inhibitors in Colorectal Cancer Alex A Adjei
Multidisciplinary Management for Timing of Rectal Surgery Axel Grothey
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.